Changes in the Local Regulation of Insulin-Like Growth Factors I and II and Insulin-Like Growth Factor-Binding Proteins in Osteoarthritis of the Canine Stifle Joint Secondary to Cruciate Ligament Rupture

Veterinary Surgery

Volumn 32, Issue 4, 2003, Pages 313-323

  Fernihough, Janet K ^a   Innes, John F ^b   Billingham, Michael E J ^c   Holly, Jeff M P ^c  

^a Novatis Inst for Medical Sciences   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

LIGAND; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C;

ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DOG; DOG DISEASE; HINDLIMB; KNEE CRUCIATE LIGAMENT; KNEE OSTEOARTHRITIS; KNEE RADIOGRAPHY; LIGAMENT RUPTURE; NONHUMAN; OSTEOARTHRITIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RADIOIMMUNOASSAY; REGULATORY MECHANISM; SURGICAL TECHNIQUE; SYNOVIAL FLUID LEVEL; TREATMENT OUTCOME; WESTERN BLOTTING; ANIMAL; ANIMAL DISEASE; ANTERIOR CRUCIATE LIGAMENT; IMMUNOLOGY; INJURY; INJURY SCALE; METABOLISM; PROSPECTIVE STUDY; RADIOGRAPHY; RUPTURE; SYNOVIAL FLUID;

CANIS FAMILIARIS;

ANIMALS; ANTERIOR CRUCIATE LIGAMENT; BLOTTING, WESTERN; DOG DISEASES; DOGS; INJURY SEVERITY SCORE; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; OSTEOARTHRITIS; PROSPECTIVE STUDIES; RADIOIMMUNOASSAY; RUPTURE, SPONTANEOUS; STIFLE; SYNOVIAL FLUID;

EID: 0041884939     PISSN: 01613499     EISSN: None     Source Type: Journal    
DOI: 10.1053/jvet.2003.50037     Document Type: Article

References (78)

1. Anderson J: The stifle, in Houlton J, Collinson R (eds): Manual of Small Animal Arthrology. Cheltenham: British Small Animal Veterinary Association, 1994, pp 280-286
2. Bennett D, May C: An "over-the-top with tibial tunnel" technique for repair of cranial cruciate ligament rupture in the dog. J Small Anim Pract 32:103-110, 1991
3. Denny HR, Barr A: An evaluation of two "over the top" techniques for anterior cruciate ligament replacement in the dog. J Small Anim Pract 25:759-769, 1984
4. Denny HR, Barr A: A further evaluation of the "over-the-top" technique for anterior cruciate ligament replacement in the dog. J Small Anim Pract 28:681-686, 1987
5. Innes JF, Barr ARS: Can owners assess outcome following treatment of canine cruciate ligament deficiency? J Small Anim Pract 39:373-378, 1998
6. Innes JF, Barr ARS: Clinical natural history of the postsurgical cruciate deficient canine stifle joint: Year 1. J Small Anim Pract 39:325-332, 1998
7. Jevens DJ, DeCamp CE, Hauptman J, et al: Use of force-plate analysis of gait to compare two surgical techniques for treatment of cranial cruciate ligament rupture in dogs. Am J Vet Res 57:389-393, 1996
8. Budsberg SC, Verstraete MC, Soutas-Little R, et al: Force plate analyses before and after stabilization of canine stifles for cruciate injury. Am J Vet Res 49:1522-1524, 1988
9. Elkins AD, Pechman R, Kearney MT, et al: A retrospective study evaluating the degree of degenerative joint diseases in the stifle joint of dogs following surgical repair of anterior cruciate ligament rupture. J Am Anim Hosp Assoc 27:533-540, 1991
10. Vasseur PB, Berry CR: Progression of stifle osteoarthrosis following reconstruction of the cranial cruciate ligament in 21 dogs. J Am Anim Hosp Assoc 28:129-136, 1992
11. Innes J, Lynch C, Bacon D, et al: Long term outcome of the post-surgical, cruciate deficient canine stifle joint. Vet Rec 147:325-328, 2000
12. Dieppe P, Kirwan J: The localization of osteoarthritis. Br J Rheum 33:201-204, 1994
13. McQuillan DJ, Handley CJ, Campbell MA, et al: Stimulation of proteoglycan biosynthesis by serum and insulin-like growth factor-I in cultured bovine articular cartilage. Biochem J 240:423-430, 1986
14. Schalkwijk J, Joosten LA, Van den berg WB, et al: Insulin-like growth factor stimulation of chondrocyte proteoglycan synthesis by human synovial fluid. Arthritis Rheum 32:66-71, 1989
15. Fosang AJ, Tyler JA, Hardingham TE: Effect of interleukin-1 and insulin-like growth factor-I on the release of proteoglycan components and hyaluronan from pig articular cartilage in explant culture. Matrix 11:17-24, 1991
16. Tyler JA: Insulin-like growth factor-I can decrease degradation and promote synthesis of proteoglycan in cartilage exposed to cytokines. Biochem J 260:543-548, 1989
17. Hardingham TE, Bayliss MT, Rayan V, et al: Effects of growth factors and cytokines on proteoglycan turnover in articular cartilage. Br J Rheum 31:1-6, 1992
18. Luyten FP, Hascall VC, Nissley SP, et al: Insulin-like growth factors maintain steady-state metabolism of proteoglycans in bovine articular cartilage explants. Arch Biochem Biophys 267:416-425, 1988
19. Mohan S, Strong D, Linkhart T, et al: Regulation and actions of insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5 in bone, physiological and clinical implications, in Baxter R, Gluckman P, Rosenfield R (eds): The Insulin-Like Growth Factors and Their Regulatory Proteins. Amsterdam: Elsevier, 1994, pp 205-215
20. Mohan S, Baylink DJ: Bone-growth factors. Clin Orthop 263:30-48, 1991
21. Keyszer GM, Heer AH, Kriegsmann J, et al: Detection of insulin-like growth factor-I and factor-II in synovial tissue specimens of patients with rheumatoid arthritis and osteoarthritis by in-situ hybridization. J Rheumatol 22:275-281, 1995
22. Baxter RC: Insulin-like growth factor (IGF)-binding proteins: Interactions with IGFs and intrinsic bioactivities. Am J Physiol Endocrinol Metab 278:E967-E976, 2000
23. Kelley KM, Oh YM, Gargosky SE, et al: Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamics. Int J Biochem Cell Biol 28:619-637, 1996
24. Jones J, Clemmons D: Insulin-like growth factors and their binding proteins: Biological actions. Endocr Rev 16:3-34, 1995
25. Guler H, Zapf J, Schmid C, et al: Insulin-like growth factors I and II in healthy man: Estimation of half-lives and production rates. Acta Endocrinol 121:753-758, 1989
26. Davies SC, Wass JAH, Ross RJM, et al: The induction of a specific protease for insulin-like growth factor binding protein-3 in the circulation during severe illness. J Endocrinol 130:469, 1991
27. Lassarre C, Binoux M: Insulin-like growth factor binding protein-3 is functionally altered in pregnancy plasma. Endocrinology 134:1254-1262, 1994
28. Lamson G, Giudice LC, Cohen P, et al: Proteolysis of IGFBP-3 may be a common regulatory mechanism of IGF action in vivo. Growth Regul 3:91-95, 1993
29. Holly JMP, Claffey DCP, Cwyfanhughes SC, et al: Proteases acting on IGFBPs: Their occurrence and physiological significance. Growth Regul 3:88-91, 1993
30. Cwyfan-Hughes S, Xu S, Fernihough JK, et al: Tissue IGFBP-3 proteolysis: Contrasting pathophysiology to that in the circulation. Prog Growth Factor Res 6:293-299, 1995
31. Whellams EJ, Maile LA, Fernihough JK, et al: Alterations in insulin-like growth factor binding protein-3 proteolysis and complex formation in the arthritic joint. J Endocrinol 165:545-556, 2000
32. Maile LA, Xu S, Cwyfan-Hughes SC, et al: Active and inhibitory components of the insulin-like growth factor binding protein-3 protease system in adult serum, interstitial, and synovial fluid. Endocrinology 139:4772-4781, 1998
33. Martin JL, Ballesteros M, Baxter RC: Insulin-like growth factor-I (IGF-I) and transforming growth factor-β-1 release IGF-binding protein-3 from human fibroblasts by different mechanisms. Endocrinology 131:1703-1710, 1992
34. Smith EP, Lu L, Chernausek SD, et al: Insulin-like growth factor-binding protein-3 (IGFBP-3) concentration in rat sertoli cell-conditioned medium is regulated by a pathway involving association of IGFBP-3 with cell-surface proteoglycans. Endocrinology 135:359-364, 1994
35. Blum WF, Jenne EW, Reppin F, et al: Insulin-like growth factor-I (IGF-I)-binding protein complex is a better mitogen than free IGF-I. Endocrinology 125:766-772, 1989
36. Conover CA, Clarkson JT, Bale LK: Factors regulating insulin-like growth factor-binding protein 3 binding, processing, and potentiation of insulin-like growth factor action. Endocrinology 137:2286-2292, 1996
37. Conover CA: Potentiation of insulin-like growth-factor (IGF) action by IGF-binding protein-3: Studies of underlying mechanism. Endocrinology 130:3191-3199, 1992
38. Fernihough JK, Billingham MEJ, Cwyfan-Hughes S, et al: Local disruption of the insulin-like growth-factor system in the arthritic joint. Arthritis Rheum 39:1556-1565, 1996
39. Tavera C, Abribat T, Reboul P, et al: IGF and IGF-binding protein system in the synovial fluid of osteoarthritic and rheumatoid arthritic patients. Osteoarthritis Cartilage 4:263-274, 1996
40. Kanety H, Shimon I, Ehrenfeld M, et al: Insulin-like growth factor I and its binding proteins 3 and 4 are increased in human inflammatory synovial fluid. J Rheumatol 23:815-818, 1996
41. Matsumoto T, Gargosky SE, Iwasaki K, et al: Identification and characterization of insulin-like growth factors (IGFs), IGF-binding proteins (IGFBPs), and IGFBP proteases in human synovial fluid. J Clin Endocrinol Metab 81:150-155, 1996
42. Neidel J, Blum WF, Schaeffer HJ: Elevated levels of insulin-like growth factor (IGF) binding protein-3 in rheumatoid arthritis synovial fluid inhibit stimulation by IGF-I of articular chondrocyte proteoglycan synthesis. Rheumatol Int 17:29-37, 1997
43. Loeser RF, Shanker G, Carlson CS, et al: Reduction in the chondrocyte response to insulin-like growth factor 1 in aging and osteoarthritis: Studies in a non-human primate model of naturally occurring disease. Arthritis Rheum 43:2110-2120, 2000
44. Dore S, Pelletier JP, Dibattista JA, et al: Human osteoarthritic chondrocytes possess an increased number of insulin-like growth-factor I binding-sites but are unresponsive to its stimulation: Possible role of IGF-1-binding proteins. Arthritis Rheum 37:253-263, 1994
45. Chevalier X, Tyler JA: Production of binding-proteins and role of the insulin-like growth-factor-I binding-protein-3 in human articular-cartilage explants. Br J Rheum 35:515-522, 1996
46. Tardif G, Reboul P, Pelletier JP, et al: Normal expression of type 1 insulin-like growth factor receptor by human osteoarthritic chondrocytes with increased expression and synthesis of insulin-like growth factor binding proteins. Arthritis Rheum 39:968-978, 1996
47. McDevitt C, Gilbertson E, Muir H: An experimental model of osteoarthritis; early morphological and biochemical changes. J Bone J Surg 59B:24-35, 1977
48. Brandt KD, Myers SL, Burr D, et al: Osteoarthritic changes in canine articular cartilage, subchondral bone, and synovium fifty-four months after transection of the anterior cruciate ligament. Arthritis Rheum 34:1560-1570, 1991
49. Hay CW, Chu QL, Budsberg SC, et al: Synovial fluid interleukin 6, tumor necrosis factor, and nitric oxide values in dogs with osteoarthritis secondary to cranial cruciate ligament rupture. Am J Vet Res 58:1027-1032, 1997
50. Pelletier JP, Lajeunesse D, Jovanovic DV, et al: Carprofen simultaneously reduces progression of morphological changes in cartilage and subchondral bone in experimental dog osteoarthritis. J Rheumatol 27:2893-2902, 2000
51. Innes J, Sharif M, Barr A: Relations between biochemical markers of osteoarthritis and other disease parameters in a population of dogs with naturally acquired osteoarthritis of the genual joint. Am J Vet Res 59:1530-1536, 1998
52. Innes J, Barr A: Can owners assess outcome following surgical treatment of canine cranial cruciate ligament deficiency? J Small Anim Pract 39:373-378, 1998
53. Innes JF, Sharif M, Barr ARS: Changes in concentrations of biochemical markers of osteoarthritis following surgical repair of ruptured cranial cruciate ligaments in dogs. Am J Vet Res 60:1164-1168, 1999
54. Innes JF, Barr ARS, Patteson MW, et al: Scintigraphy in the evaluation of osteoarthritis of the canine stifle joint: Relationship with clinical, radiographic and surgical observations. Vet Comp Orthop Traumatol 9:53-59, 1996
55. Innes J, Costello M, Barr A, et al: Inter-rater agreement for radiographic assessment of osteoarthritis of the canine stifle joint. Vet Radiol 37:479, 1996
56. Bowsher RR, Lee W-H, Apathy JM, et al: Measurement of IGF-II in physiological fluids and tissues. An improved extraction procedure and RIA for human and rat fluids. Endocrinology 128:805-814, 1991
57. Maxwell A, Butterwick R, Yateman M, et al: Nutritional modulation of canine insulin-like growth factors and their binding proteins. J Endocrinol 158:77-85, 1998
58. Helle SI, Anker GB, Meadows KA, et al: Alterations in the insulin-like growth factor system during the menstrual cycle in normal women. Maturitas 28:259-265, 1998
59. Crosby SR, Anderton CD, Westwood M, et al: Measurement of insulin-like growth factor-II in human plasma using a specific monoclonal antibody-based 2-site immunoradiometric assay. J Endocrinol 137:141-150, 1993
60. Lassarre C, Lalou C, Perin L, et al: Protease-induced alteration of insulin-like growth-factor binding protein-3 as detected by radioimmunoassay: Agreement with ligand blotting data. Growth Regul 4:48-55, 1994
61. Davies SC, Holly JMP, Coulson VJ, et al: The presence of cation-dependent proteases for insulin-like growth-factor binding-proteins does not alter the size distribution of insulin-like growth-factors in pregnancy. Clin Endocrinol 34:501-506, 1991
62. Farndale RW, Buttle DJ, Barrett AJ: Improved quantification and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta 883: 173-177, 1986
63. Thonar E, Lenz M, Klintworth G, et al: Quantification of keratan sulphate in blood as a marker of cartilage catabolism. Arthritis Rheum 28:1367-1376, 1985
64. Creamer P, Sharif M, George E, et al: Intra-articular hyaluronic acid in osteoarthritis of the knee: An investigation into mechanisms of action. Osteoarthritis Cartilage 2:133-140, 1994
65. Rogachefsky RA, Dean DD, Howell DS, et al: Treatment of canine osteoarthritis with IGF-1 and sodium pentosan polysulphate. Osteoarthritis Cartilage 1:105-114, 1993
66. Schneiderman R, Rosenberg N, Hiss J, et al: Concentration and size distribution of insulin-like growth factor-I in human normal and osteoarthritic synovial fluid and cartilage. Arch Biochem Biophys 324:173-188, 1995
67. Matsumoto T, Yamashita S, Rosenfeld RG: Increased levels of IGF-I and IGFBP-3 in synovial fluids of patients with rheumatoid arthritis. Endocr J 45:S141-S144, 1998
68. Kratz G, Lake M, Gidlund M: Insulin-like growth factor-I and factor-II and their role in the reepithilialization of wounds: Interactions with insulin-like growth-factor binding-protein type-1. Scand J Plast Reconstr Surg Hand Surg 28:107-112, 1994
69. Steenfos HH, Jansson JO: Gene expression of insulin-like growth factor-I and IGF-I receptor during wound healing in rats. Eur J Surg 158:327-331, 1992
70. Gartner MH, Benson JD, Caldwell MD: Insulin-like growth factor-I and factor-II expression in the healing wound. J Surg Res 52:389-394, 1992
71. Letson AK, Dahners LE: The effect of combinations of growth-factors on ligament healing. Clin Orthop 308:207-212, 1994
72. Kluge A, Zimmermann R, Munkel B, et al: Insulin-like growth factor-II is an experimental stress-inducible gene in a porcine model of brief coronary occlusions. Cardiovasc Res 29:708-716, 1995
73. Innes J: Osteoarthritis of the Canine Stifle Joint. Bristol: University of Bristol, 1997
74. Gilbertson E: Development of periarticular osteophytes in experimentally induced osteoarthritis in the dog. A study using microradiographic, microangiographic and fluorescent bone-labelling techniques. Ann Rheum Dis 34:12-25, 1975
75. Middleton J, Arnott N, Walsh S, et al: Osteoblasts and osteoclasts in adult human osteophyte tissue express the messenger-RNAs for insulin-like growth-factor-I and growth-factor-II and the type-1 IGF receptor. Bone 16:287-293, 1995
76. Middleton J, Manthey A, Tyler J: Insulin-like growth-factor (IGF) receptor, IGF-I, interleukin-1-β (IL-1-β), and IL-6 messenger-RNA expression in osteoarthritic and normal human cartilage. J Histochem Cytochem 44:133-141, 1996
77. Verschure PJ, VanMarle J, Joosten LAB, et al: Localization of insulin-like growth factor-I receptor in human normal and osteoarthritic cartilage in relation to proteoglycan synthesis and content. Br J Rheum 35:1044-1055, 1996
78. Martel-Pelletier J, Di Battista JA, Lajeunesse D, et al: IGF/ IGFBP axis in cartilage and bone in osteoarthritis pathogenesis. Inflamm Res 47:90-100, 1998